Table 1 Characteristics on adverse event reports related to misoprostol from the FAERS database.

From: A disproportionality analysis of FDA adverse event reporting system events for misoprostol

Characteristics

Case number, n

Case proportion, %

Year

 2004

32

1.57

 2005

37

1.82

 2006

52

2.56

 2007

56

2.76

 2008

43

2.12

 2009

31

1.53

 2010

44

2.17

 2011

35

1.72

 2012

43

2.12

 2013

53

2.61

 2014

52

2.56

 2015

33

1.62

 2016

71

3.49

 2017

218

10.73

 2018

85

4.18

 2019

118

5.81

 2020

453

22.29

 2021

254

12.5

 2022

154

7.58

 2023

114

5.61

 2024

54

2.66

Gender

 Female

1541

75.84

 Male

176

8.66

 Unknown

315

15.5

Age

 <18

75

3.69

 18 ~ 55

1036

50.98

 55 ~ 65

37

1.82

 >=65

47

2.31

 Unknown

837

41.19

Reporter

 Consumer

792

38.98

 Pharmacist

418

20.57

 Physician

404

19.88

Other health-professional

321

15.8

 Unknown

72

3.54

 Lawyer

24

1.18

 Registered Nurse

1

0.05

Reported countries

 Other

731

35.97

 Germany

453

22.29

 United States

379

18.65

 France

175

8.61

 China

99

4.87

 United Kingdom

75

3.69

 Italy

65

3.20

 Denmark

55

2.71

Route

 Other

639

31.45

 Oral

535

26.33

 Transplacental

408

20.08

 Vaginal

343

16.88

 Sublingual

50

2.46

 Buccal

35

1.72

 Rectal

22

1.08

Outcomes

 Other serious

1264

53.67

 Hospitalization

560

23.78

 Life threatening

187

7.94

 Death

143

6.07

 Congenital anomaly

94

3.99

 Disability

86

3.65

 Required intervention to Prevent Permanent Impairment/Damage

21

0.89

Adverse event occurrence time - medication date (days)

  

 <7

813

65.25

 7 ~ 28

32

2.57

 28 ~ 60

13

1.04

 >=60

22

1.77

 Unknown

366

29.37

Indications

 Abortion

135

6.63

 Abortion induced

471

23.13

 Abortion spontaneous

51

2.50

 Induced labour

80

3.93

 Labour induction

563

27.65

 Others

408

20.04

 Postpartum haemorrhage

31

1.52

 Unknown

297

14.59